J. Anthony Ware - Net Worth and Insider Trading
J. Anthony Ware Net Worth
The estimated net worth of J. Anthony Ware is at least $1 Million dollars as of 2026-09-11. J. Anthony Ware is the Director of First Tracks Biotherapeutics Inc and owns about 15,660 shares of First Tracks Biotherapeutics Inc (TRAX) stock worth over $593,514. J. Anthony Ware is also the Director of AnaptysBio Inc and owns about 9,630 shares of AnaptysBio Inc (ANAB) stock worth over $530,902. Details can be seen in J. Anthony Ware's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J. Anthony Ware has not made any transactions after 2026-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J. Anthony Ware
J. Anthony Ware Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J. Anthony Ware owns 2 companies in total, including AnaptysBio Inc (ANAB) , and First Tracks Biotherapeutics Inc (TRAX) .
Click here to see the complete history of J. Anthony Ware’s form 4 insider trades.
Insider Ownership Summary of J. Anthony Ware
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ANAB | AnaptysBio Inc | 2025-12-23 | director |
| TRAX | First Tracks Biotherapeutics Inc | 2026-09-02 | director |
J. Anthony Ware Latest Holdings Summary
J. Anthony Ware currently owns a total of 2 stocks. Among these stocks, J. Anthony Ware owns 15,660 shares of First Tracks Biotherapeutics Inc (TRAX) as of September 2, 2026, with a value of $593,514 and a weighting of 52.78%. J. Anthony Ware also owns 9,630 shares of AnaptysBio Inc (ANAB) as of December 23, 2025, with a value of $530,902 and a weighting of 47.22%.
Latest Holdings of J. Anthony Ware
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRAX | First Tracks Biotherapeutics Inc | 2026-09-02 | 15,660 | 37.90 | 593,514 |
| ANAB | AnaptysBio Inc | 2025-12-23 | 9,630 | 55.13 | 530,902 |
Holding Weightings of J. Anthony Ware
J. Anthony Ware Form 4 Trading Tracker
According to the SEC Form 4 filings, J. Anthony Ware has made a total of 1 transactions in First Tracks Biotherapeutics Inc (TRAX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in First Tracks Biotherapeutics Inc is the sale of 39,265 shares on September 2, 2026, which brought J. Anthony Ware around $2 Million.
According to the SEC Form 4 filings, J. Anthony Ware has made a total of 1 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AnaptysBio Inc is the sale of 3,900 shares on December 23, 2025, which brought J. Anthony Ware around $193,362.
Insider Trading History of J. Anthony Ware
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
J. Anthony Ware Trading Performance
GuruFocus tracks the stock performance after each of J. Anthony Ware's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J. Anthony Ware is 11.1%. GuruFocus also compares J. Anthony Ware's trading performance to market benchmark return within the same time period. The performance of stocks bought by J. Anthony Ware within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J. Anthony Ware's insider trading performs compared to the benchmark.
Performance of J. Anthony Ware
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.72 | | | | | |
| Relative Return to S&P 500(%) | -0.52 | | | | | |
J. Anthony Ware Ownership Network
Ownership Network List of J. Anthony Ware
Ownership Network Relation of J. Anthony Ware
J. Anthony Ware Owned Company Details
What does AnaptysBio Inc do?
Who are the key executives at AnaptysBio Inc?
J. Anthony Ware is the director of AnaptysBio Inc. Other key executives at AnaptysBio Inc include Chief Financial Officer Christopher M. Murphy , General Counsel Eric J Loumeau , and Chief Medical Officer Paul F. Lizzul .
AnaptysBio Inc (ANAB) Insider Trades Summary
Over the past 18 months, J. Anthony Ware made 1 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 3,900. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 65,713 shares made by Eric J Loumeau , a net sale of 33,511 shares made by Dennis Mulroy , and a net sale of 56,471 shares made by Daniel Faga .
In summary, during the past 3 months, insiders sold 0 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 240,030 shares of AnaptysBio Inc (ANAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 240,030 shares.
AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
AnaptysBio Inc Insider Transactions
J. Anthony Ware Mailing Address
Above is the net worth, insider trading, and ownership report for J. Anthony Ware. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, J. Anthony Ware's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
